• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 29, 2016

View Archived Issues

Tesaro initiates phase I study of TSR-022 for advanced solid tumors

Read More

New phase I trial explores use of lentivirus alpha-gal A transduced CD34+ cells in Fabry disease

Read More

NIAID-sponsored phase I trial of yellow fever vaccine begins

Read More

GSK reflects on milestones of second quarter 2016

Read More

Methanobactin reverses mitochondrial impairment and acute liver failure in model of Wilson disease

Read More

Ono seeks Japanese approval for Opdivo for head and neck cancer

Read More

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

Read More

International partnership to tackle the threat posed by antimicrobial resistance

Read More

European orphan drug designation awarded to volanesorsen for familial partial lipodystrophy

Read More

FIOCRUZ patents antituberculosis agents

Read More

University of Illinois discloses antifungal compounds

Read More

Auspex Pharmaceuticals describes modulators of melatonin receptors

Read More

Hitgen reports HDAC6 inhibitors

Read More

FDA grants breakthrough therapy designation to AVXS-101 for spinal muscular atrophy

Read More

Phase I results for Abeta oligomer receptor antagonist CT-1812

Read More

First-in-human results on LY-3002813

Read More

FDA grants fast track designation for CLBS-03 for the treatment of recent onset type 1 diabetes

Read More

Pfenex grants Jazz Pharmaceuticals rights to early-stage hematology product candidates

Read More

Omeros receives scientific advice from EMA on phase III program for OMS-721

Read More

ProterixBio earns grant from MJFF

Read More

Pfizer reports promising topline results from OCTAVE Sustain trial of Xeljanz

Read More

Editas Medicine and Fondazione Telethon and Ospedale San Raffaele form collaboration

Read More

Western Oncolytics and Pfizer enter immuno-oncology research collaboration

Read More

New company Nodthera Limited to focus on inhibitors of NLRP3

Read More

Adaptimmune Therapeutics gains access to EMA's PRIME initiative for T-cell therapy

Read More

Janssen files for approval of darunavir/cobicistat combination tablets in Japan

Read More

Supplemental application filed for Somatuline in Japan for neuroendocrine tumors

Read More

Protagonist Therapeutics receives grant to develop hepcidin mimetics

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe